Mouth rinse study for kids getting chemo
Part of Mouth & dental clinical trials.
This trial tests three different mouth rinses—sodium bicarbonate, saline, and black mulberry syrup—to see which one best prevents or lessens mouth sores (oral mucositis) in children receiving chemotherapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Child is between 6 and 18 years old
- Is currently getting chemotherapy and staying in the hospital for it
- Can eat and drink by mouth
- Child and family agree to participate and sign consent forms
- No mouth sores at the start of the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether using cold packs on the mouth and artificial saliva can help prevent painful mouth sores that chemotherapy sometimes causes.
This trial tests whether Orosol® can reduce mouth sores caused by chemotherapy or radiation. If you have moderate to severe mouth sores from these treatments, it may help improve comfort and healing.
This study tests whether a coconut oil mouth rinse can help prevent mouth sores in children and young adults who are about to receive intense chemotherapy for a stem cell transplant. If mouth sores can be prevented, it may make treatment more comfortable and reduce complications.
This study tests whether a special light treatment (photobiomodulation) can prevent or treat mouth sores caused by chemotherapy in children with certain cancers. It may help reduce pain and make eating and drinking easier during treatment.
This study tests a new cream/gel applied to the mouth to lower the chance of severe mouth sores in people receiving radiation for head and neck cancer. It also looks at how treatment affects quality of life using patient questionnaires.
This trial tests if adding ozone therapy to a special mouthwash routine can help heal painful mouth sores caused by chemotherapy or radiation. It is for cancer patients with mild to moderate oral mucositis.
Hear when a new Oral Mucositis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.